AccurEdit
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
374 Great Rd Apt 12, Acton, Massachusett...Website
www.accuredit.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About AccurEdit
AccurEdit Therapeutics specializes in in vivo gene editing medicine, focusing on delivering innovative therapies for patients in need. The company has developed a potentially best-in-class gene editing product for ATTR, demonstrating significant serum TTR reduction without off-target effects. With a robust end-to-end gene editing platform, they offer advanced RNA synthesis, patented editing technologies, and efficient delivery systems. Their primary clients include patients requiring cutting-edge gene therapies in both China and the US.Explore more
Popular SearchesAccurEditAccuredit Therapeutics Co LtdAccuredit Therapeutics 锐正基因（苏州）有限公司SIC Code 28,283NAICS Code 32,325Show moreAccurEdit Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AccurEdit your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if AccurEdit had a recent Job posting/layoffs
Earning: See what the market has to say on AccurEdit recently announced quarterly report
AccurEdit, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if AccurEdit is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at AccurEdit
Funding: Get notified immidiatlly once AccurEdit has new funding data
Product Launch: Get notified when AccurEdit launches new products
Check if AccurEdit has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to AccurEdit
Compare insights from companies similar to AccurEdit, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AccurEdit is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AccurEdit is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AccurEdit.
AccurEdit Tech Stack
A closer look at the technologies used by AccurEdit
AccurEdit News & Media
AccurEdit Therapeutics to present at the 2025 Annual Meeting of the American Society of Gene & Cell Therapy
SUZHOU, China, May 12, 2025 /PRNewswire/ -- AccurEdit Therapeutics today announced that its three abstracts have been selected for presentation, including one oral presentation on ART001, at the upcoming American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting being held from...AccurEdit Therapeutics' LNP-based In Vivo Gene Editing Product ART001 Obtained Orphan Drug Designation from the FDA
CAMBRIDGE, Mass., March 25, 2025 /PRNewswire/ -- AccurEdit Therapeutics today announced that its innovative in vivo gene editing product, ART001, has obtained Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA). ART001, which utilizes lipid nanoparticle (LNP) technology for targeted gene editing, is designed for the treatment of transthyretin amyloidosis (ATTR), a rare and life-threatening disease. It is currently the first and only LNP-based in vivo gene editing produ
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AccurEdit
Sign Up For FreeTo access detailed company insights
AccurEdit Therapeutics specializes in in vivo gene editing medicine, focusing on delivering innovative therapies for patients in need. The company has developed a potentially best-in-class gene editing product for ATTR, demonstrating significant serum TTR reduction without off-target effects. With a robust end-to-end gene editing platform, they off... Read More
